Sort
11,323 grants matching “glioblastoma”
Transcriptional regulation of gliogenesis in the CNS
$342,344Benjamin Deneen · Baylor College Of Medicine · R01 · FY2016 · NS
Transcriptional regulation of gliogenesis in the CNS
$342,344Benjamin Deneen · Baylor College Of Medicine · R01 · FY2017 · NS
Transgenic Mouse and Biobank Core
$342,316Ronald Anthony Depinho · Dana-Farber Cancer Inst · P01 · FY2009 · CA
Computational and Experimental Modeling of Alternative Polyadenylation
$342,290Wei Li · University Of California-Irvine · R01 · FY2024 · CA
Site Specific Drug Delivery with Light-responsive Conjugates for Photo-biomodulation
$342,275Youngjae You · State University Of New York At Buffalo · R01 · FY2023 · GM
Clinical Relevance of Chromosome 5p/9p/20q/8q Germline Alterations in Glioma
$342,209Panagiotis Z Anastasiadis · Mayo Clinic Rochester · P50 · FY2015 · CA
Project 3: Targeting epigenetic regulators in cancer
$342,135Jacqueline A. Lees · Massachusetts Institute Of Technology · P01 · FY2019 · CA
phase 1 adaptive dose-escalation study of mycophenolate mofetil (MMF) in combination with temozolomide (TMZ) for patients with newly diagnosed glioblastoma
$342,106Maciej S Lesniak · Northwestern University At Chicago · P50 · FY2020 · CA
Cellular plasticity and equilibrium in GBM progression
$342,103Atique U. Ahmed · Northwestern University At Chicago · R01 · FY2019 · NS
Treatment of glioma with nanocombretastatin with MRI monitoring
$341,981Meser M. Ali · Henry Ford Health System · R01 · FY2016 · CA
Neural Progenitor Cells as Cancer Therapy Vectors
$341,888St. Jude Children'S Research Hospital · R01 · FY2005 · CA
Circulating Cell-Free DNA as a Personalized Biomarker to Diagnose and Monitor Glioblastoma
$341,867Hunter Reeve Underhill · University Of Utah · R37 · FY2023 · CA
INTERACTIONS OF FIBRINOGEN WITH p75NTR
$341,825Katerina Akassoglou · University Of California, San Diego · R01 · FY2006 · NS
Regulation of the tumor suppressor PTEN
$341,760Burnham Institute For Medical Research · R01 · FY2003 · CA
Mechanism-based drug repurposing and novel treatments for glioblastoma
$341,706Mark D Noble · University Of Rochester · R01 · FY2019 · CA
The Role of White Matter Progenitors in Glioma Formation and Progression
$341,692Peter D Canoll · Columbia University Health Sciences · R01 · FY2014 · NS
Development of Natural Product Leads as Anticancer Therapeutics
$341,671John Beutler · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Biospecimen and Biostatistics Core
$341,630Susan M Chang · University Of California, San Francisco · P01 · FY2014 · CA
Project 2: Targeting metabolic vulnerabilities in glioblastoma
$341,625David A. Nathanson · University Of California Los Angeles · P50 · FY2020 · CA
Developing therapeutic strategies to elicit metabolic synthetic lethality in glioblastoma
$341,614Prakash Chinnaiyan · William Beaumont Hospital Research Inst · R01 · FY2020 · NS
Neural Progenitor Cells as Cancer Therapy Vectors
$341,584Karen S Aboody · Beckman Research Institute/City Of Hope · R01 · FY2008 · CA
Improving therapy of glioblastoma multiforme by enhancing therapeutic drug delive
$341,566Michael R McDevitt · Sloan-Kettering Inst Can Research · R01 · FY2015 · CA
Project 1: Sex-specific developmental epigenetics in gliomagenesis
$341,521Joshua B Rubin · Cleveland Clinic Lerner Com-Cwru · P01 · FY2024 · CA
Cyclophilin B as a therapeutic target in glioblastoma
$341,518Richard J Bram · Mayo Clinic Rochester · R01 · FY2014 · NS
Genetic Dissection of Glioblastoma: Cell of Origin
$341,472Robert M Bachoo · Ut Southwestern Medical Center · R01 · FY2012 · NS